Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells

Anna R Kwilas; Andressa Ardiani; Renee N Donahue; Dana Aftab; James W Hodge

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells

【24h】

Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells

机译：卡博替尼（一种小分子酪氨酸激酶抑制剂）对肿瘤微环境的免疫允许和免疫介导的肿瘤细胞杀伤的影响

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer 》 |2014年第s3期| 共页
作者
Anna R Kwilas; Andressa Ardiani; Renee N Donahue; Dana Aftab; James W Hodge;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Dual effects of a targeted small-molecule inhibitor (cabozantinib) on immune-mediated killing of tumor cells and immune tumor microenvironment permissiveness when combined with a cancer vaccine [J] . Anna R Kwilas, Andressa Ardiani, Renee N Donahue, Journal of Translational Medicine . 2014 ,第1期

机译：靶向小分子抑制剂（cabozantinib）与癌症疫苗联合使用对免疫介导的杀伤肿瘤细胞和免疫肿瘤微环境的双重影响
2. Checkpoint molecule PD-1-assisted CD8 +/sup T lymphocyte count in tumor microenvironment predicts overall survival of patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors [J] . Jiaxi Yao, Wei Xi, Yanjun Zhu, Cancer Management and Research . 2018 ,第4期

机译：肿瘤微环境中检查点分子PD-1辅助的CD8 + T淋巴细胞计数可预测酪氨酸激酶抑制剂治疗的转移性肾细胞癌患者的总体生存率
3. The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies. [J] . Ozao-Choy J, Ma G, Kao J, Cancer research: The official organ of the American Association for Cancer Research, Inc . 2009 ,第6期

机译：酪氨酸激酶抑制剂在基于免疫的癌症治疗中逆转免疫抑制和调节肿瘤微环境的新作用。
4. SHORT-TERM TUMOR RESPONSE TO TYROSINE KINASE INHIBITORS VERSUS LONG-TERM SURVIVAL IN MAST CELL TUMORS: FOLLOW-UP DATA FROM A PIVOTAL FIELD STUDY WITH MASITINIB [C] . Olivier Hermine Annual Conference of the Veterinary Cancer Society . 2009

机译：短期肿瘤对酪氨酸激酶抑制剂的反应与肥大细胞肿瘤的长期存活：来自Masitinib的关键田间研究的后续数据
5. Analysis of pp60c-src and pp62c-yes intracellular protein tyrosine kinase function in colon tumor cell growth regulation using herbimycin A, a tyrosine kinase specific inhibitor. [D] . Garcia, Roy. 1995

机译：使用酪氨酸激酶特异性抑制剂除草霉素A分析pp60c-src和pp62c-yes细胞内蛋白酪氨酸激酶在结肠肿瘤细胞生长调节中的功能。
6. Effects of Cabozantinib a small molecule tyrosine kinase inhibitor on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells [O] . Anna R Kwilas, Andressa Ardiani, Renee N Donahue, 2014

机译：卡博替尼（一种小分子酪氨酸激酶抑制剂）对肿瘤微环境的免疫允许和免疫介导的肿瘤细胞杀伤的影响
7. Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells [O] . 2014

机译：卡博替尼（一种小分子酪氨酸激酶抑制剂）对肿瘤微环境的免疫允许和免疫介导的肿瘤细胞杀伤的影响

Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells

著录项

相似文献

相关主题

期刊订阅